Adaptive Biotechnologies Corporation
ADPT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $2 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 59.6% | 12.3% | 10.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 80.7% | 69.4% | 67.6% | 62% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 18% | -30.8% | -56.4% | -55.5% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 10.2% | -43.5% | -56.9% | -71% |
| EPS Diluted | 0.06 | -0.17 | -0.2 | -0.23 |
| % Growth | 135.3% | 15% | 13% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |